Mayo Clinic Building- Phoenix — Phoenix, Arizona

Mayo Clinic Building- Phoenix is a clinical research site located in Phoenix, Arizona, United States 85054.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Mayo Clinic Building- Phoenix has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Colorectal Cancer, Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis, Symptomatic Hypertrophic Cardiomyopathy (HCM).

Sponsors: Pfizer, Cytokinetics, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mayo Clinic Building- Phoenix?

Mayo Clinic Building- Phoenix has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mayo Clinic Building- Phoenix conducted?

Mayo Clinic Building- Phoenix has 5 clinical trials on record, with 4 currently active. Their work covers Metastatic Colorectal Cancer, Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis, Symptomatic Hypertrophic Cardiomyopathy (HCM).

Is Mayo Clinic Building- Phoenix accredited by Crixeo Clinical Trials?

Mayo Clinic Building- Phoenix has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mayo Clinic Building- Phoenix?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.